Calcitonin gene-related peptide (CGRP) and CGRP receptor expression at the human implantation site

被引:27
|
作者
Tsatsaris, V
Tarrade, A
Merviel, P
Garel, JM
Segond, N
Jullienne, A
Evain-Brion, D
机构
[1] Univ Paris 05, U427, Fac Sci Pharmaceut & Biol, INSERM, F-75006 Paris, France
[2] INSERM, U349, F-75010 Paris, France
[3] Ctr Viggo Peterson, F-75010 Paris, France
来源
关键词
D O I
10.1210/jc.2002-020138
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Calcitonin gene-related peptide (CGRP) is a 37-amino acid neuropeptide produced by tissue-specific alternative splicing of the primary transcript of the calcitonin gene. The objectives of this study were: 1) to determine the expression of CGRP and its receptor at the human implantation site, and 2) to examine the possible in vitro effect of this neuropeptide on two major partners of implantation, decidual cells and extravillous cytotrophoblasts. Immunohistological analysis of first-trimester placental chorionic villi showed CGRP in decidual cells and glandular cells, but not in extravillous trophoblast cells. CGRP expression was confirmed in cultured decidual cells by Southern blot analysis and immunocytochemistry and by RIA in culture medium. Transcripts of calcitonin receptor-like receptor were detected by Southern blot analysis of RT-PCR amplicons from both decidual and extravillous trophoblast cells, whereas transcripts for the receptor activity-modifying protein 1 were detected in decidual cells only. In vitro, CGRP stimulated cAMP production but not nitric oxide (NO) release by cultured decidual cells; in contrast CGRP increased NO release but not cAMP production in cultured extravillous trophoblasts. The presence of NO synthase (endothelial and inducible) was confirmed by immunodetection in extravillous trophoblasts, both in situ and in vitro. This study points to a paracrine and autocrine effect of CGRP on decidual and extravillous trophoblast cells, two major actors in implantation.
引用
收藏
页码:4383 / 4390
页数:8
相关论文
共 50 条
  • [21] Peptide Antagonists of the Calcitonin Gene-Related Peptide (CGRP) Receptor With Improved Pharmacokinetics and Pharmacodynamics
    Miranda, Les P.
    Shi, Licheng
    Holder, Jerry R.
    Wright, Marie
    Gegg, Colin V.
    Johnson, Eileen
    Wild, Kenneth
    Stenkilsson, Michael
    Doellgast, George
    Manning, Barton H.
    Salyers, Kevin
    BIOPOLYMERS, 2013, 100 (04) : 422 - 430
  • [22] Non-peptide calcitonin gene-related peptide (CGRP) receptor antagonists.
    Daines, RA
    Sham, KKC
    Taggart, JJ
    Kingsbury, WD
    Chan, J
    Breen, A
    Disa, J
    Aiyar, N
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 214 : 237 - MEDI
  • [23] Rimegepant Calcitonin gene-related peptide (CGRP) receptor antagonist Treatment of migraine
    Lionetto, L.
    Capi, M.
    Curto, M.
    Cipolla, F.
    Guglielmetti, M.
    Martelletti, P.
    DRUGS OF THE FUTURE, 2019, 44 (08) : 635 - 642
  • [24] Zavegepant Calcitonin gene-related peptide (CGRP) receptor antagonist Treatment of migraine
    Cipolla, F.
    Capi, M.
    Lionetto, L.
    De Bernardini, D.
    De Angelis, V
    Martelletti, P.
    DRUGS OF THE FUTURE, 2021, 46 (04) : 281 - 288
  • [25] Calcitonin gene-related peptide (CGRP) receptor antagonists: Novel aspartates and succinates
    Luo, Guanglin
    Chen, Ling
    Pin, Sokhom S.
    Xu, Cen
    Conway, Charles M.
    Macor, John E.
    Dubowchik, Gene M.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (08) : 2912 - 2916
  • [26] Ubrogepant Calcitonin gene-related peptide (CGRP) receptor antagonist Treatment of migraine
    Gras, J.
    DRUGS OF THE FUTURE, 2019, 44 (11) : 869 - 879
  • [27] CALCITONIN GENE-RELATED PEPTIDE RECEPTOR ANTAGONIST HUMAN CGRP-(8-37)
    CHIBA, T
    YAMAGUCHI, A
    YAMATANI, T
    NAKAMURA, A
    MORISHITA, T
    INUI, T
    FUKASE, M
    NODA, T
    FUJITA, T
    AMERICAN JOURNAL OF PHYSIOLOGY, 1989, 256 (02): : E331 - E335
  • [28] Calcitonin gene-related peptide (CGRP) receptor antagonists: Investigations of a pyridinone template
    Nguyen, Diem N.
    Paone, Daniel V.
    Shaw, Anthony W.
    Burgey, Christopher S.
    Mosser, Scott D.
    Johnston, Victor
    Salvatore, Christopher A.
    Leonard, Yvonne M.
    Miller-Stein, Cynthia M.
    Kane, Stefanie A.
    Koblan, Kenneth S.
    Vacca, Joseph P.
    Graham, Samuel L.
    Williams, Theresa M.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (02) : 755 - 758
  • [29] Azepino-indazoles as calcitonin gene-related peptide (CGRP) receptor antagonists
    Mercer, Stephen E.
    Chaturvedula, Prasad V.
    Conway, Charles M.
    Cook, Deborah A.
    Davis, Carl D.
    Pin, Sokhom S.
    Macci, Robert
    Schartman, Richard
    Signor, Laura J.
    Widmann, Kimberly A.
    Whiterock, Valerie J.
    Chen, Ping
    Xu, Cen
    Herbst, John J.
    Kostich, Walter A.
    Thalody, George
    Macor, John E.
    Dubowchik, Gene M.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2021, 31
  • [30] Effect of the calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant in human cranial arteries
    Edvinsson, Lars
    Chan, Kayi Y.
    Eftekhari, Sajedeh
    Nilsson, Elisabeth
    de Vries, Rene
    Saveland, Hans
    Dirven, Clemens M. F.
    Danser, A. H. Jan
    MaassenVanDenBrink, Antoinette
    CEPHALALGIA, 2010, 30 (10) : 1233 - 1240